Bococizumab is a novel anti-PCSK9 antibody specifically developed to treat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol amounts. By neutralizing https://junaidblfh560168.wikicommunications.com/7348641/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia